Please select the option that best describes you:

How do you manage severe Raynaud's phenomenon with ulceration in scleroderma patients that is refractory to oral agents (CCBs, PDEis, ARBs, and ERAs)?  



Answer from: at Academic Institution
Sign in or Register to read more

Answer from: at Community Practice
Sign in or Register to read more